Loading…

Sudden deaths following influenza vaccination: Can this be expected?

Summary Background In November 2006, four Dutch people, aged 53, 58, 80 and 88, died unexpectedly on the day they had received their influenza vaccination. A rapid epidemiological assessment was needed to quantify the risk of a causal association. Methods Using routinely available data on age-strati...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2008-01, Vol.26 (3), p.379-382
Main Authors: van der Sande, M.A.B, van Asten, L, Straus, S.M.J.M, Schim van der Loeff, M.F, Wallinga, J, Conyn-van Spaendonck, M.A.E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background In November 2006, four Dutch people, aged 53, 58, 80 and 88, died unexpectedly on the day they had received their influenza vaccination. A rapid epidemiological assessment was needed to quantify the risk of a causal association. Methods Using routinely available data on age-stratified population size, cardiovascular mortality, and vaccination coverage, a daily rate and daily risk of sudden death per 5-year age-group was calculated. A cumulative probability that at least one person in four specific age-groups would die on the day of vaccination was calculated using a binomial distribution. No assumptions on deaths in other age groups were included. Results The overall likelihood that at least one person in each of the four age categories 50–54, 55–59, 80–84 and 85–89 would die suddenly on the day of influenza vaccination in the Netherlands was calculated to be 0.016. This was 330 times more likely than nobody dying in each of these categories, and 45 times less likely than the most probable outcome. Conclusion We concluded that there was a small but real chance of the four deaths occurring without a causal link to the vaccination. Policy decisions regarding unexpected deaths following vaccination can benefit from a rapid epidemiological evaluation.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2007.11.006